ESMO Update: State of the Art in Early Phase Oncology Trial Design
November 14, 2018 - Toronto ON CAXtalks
fbonilla@xtalks.com
Phone:4169776555
The webinar will be split into four parts, including: An introduction into how Phase I studies have evolved to meet development objectives A discussion of where Phase I design is heading, with a look at whether 3+3 is still the gold standard and what could replace it The importance of pre-feasibility consultation with specialist oncology sites A live Q&A with expert speakers
This website uses cookies to ensure you get the best experience on our website. Learn more